Detection of the first gross CDC73 germline deletion in an HPT‐JT syndrome family
Alberto Cascón(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Juan C. Cigudosa(Centro Nacional de Epidemiología), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Iñigo Landa(Inserm), Mauro Boronat Costa(Hospital Universitario Insular de Gran Canaria), Alfredo Santana(Universitat de Miguel Hernández d'Elx), Javier Suela(Centro Nacional de Epidemiología), Iñaki Comino‐Méndez(Breast Cancer Now), Carlos Vázquez Huarte‐Mendicoa(Hospital Materno-Infantil), Rocío Letón, Lydia Sánchez(Spanish National Cancer Research Centre), Luis J. Leandro‐García(Spanish National Cancer Research Centre)
Cited by 48
Related Papers
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
|JAMA Oncology|2019|425
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
|Human Molecular Genetics|2013|394
<i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
|Clinical Cancer Research|2012|330